Newsletter | June 18, 2024

06.18.24 -- Cannabinoids Show Promise As New Treatment For Alzheimer's Disease

FEATURED EDITORIAL

Cannabinoids Show Promise As New Treatment For Alzheimer's Disease

Cannabinoids and their innate interaction with the endocannabinoid system, specifically with neuronal functioning, present an attractive therapeutic pathway for Alzheimer's disease, explains Eric Hsu, Ph.D., senior vice president of preclinical research and development at InMed Pharmaceuticals. 

INDUSTRY INSIGHTS

Challenges Associated With In-Use Simulated Administration Of Biologics

Explore some of the more challenging aspects surrounding in-use testing for parenteral delivery along with potential strategies to address these issues.

Developing A Comprehensive Regulatory Approach For LNP Drugs

The path to regulatory approval for LNPs demands carefully considered strategies. By adopting proactive and strategic approaches, developers can overcome hurdles on the path to approval.

Design Of Experiments Approach To Enabling Studies For Process Validation

A recent project applied process improvement methodology to the process validation step that ultimately provided not only an optimized, robust process but also an economic advantage.

Evaluating CAR T-Cell Therapy Recruitment And Efficacy

Learn about Organ-on-a-Chip technology and how it can be employed to assess the efficacy of CAR T-cell therapies against solid tumors.

What Is A Viral Vector?

Review a novel adenovirus production process that offers scalable, single-use equipment-compatible solutions, reducing production time and cross-contamination risks.

Rapid, Material-Sparing Feasibility Screening For Hot Melt Extrusion

Discover a screening process to quickly assess HME feasibility that yields more accurate predictions for API loading and degradation while saving material and time compared to traditional approaches.

MOST POPULAR NEWS

Breakthrough From King's Scientists Could Speed Up Discovery Of New Antibiotics

Shaperon & Dong-A ST Sign MOU For Nanobody-Based New Drug Development

Hoth Therapeutics Announces Joint Dev Agreement With Wise Systems International SRL

Eilean Therapeutics Announces FDA Clearance Of IND App For Lomonitinib

60 Degrees Pharmaceuticals Receives FDA ODD For Tafenoquine

Protein Study Could Help Researchers Develop New Antibiotics

Peptidomimetics Open New Opportunities In Drug Discovery

Sibylla Biotech & MD Anderson Announce Strategic Collaboration To Discover & Develop FIDs

Cyrus Biotechnology Spins Out Levitate Bio To Bring Customized AI Solutions To Biopharma

BioStrand, ImmunoPrecise Antibodies' Subsidiary, Announces Commercial Release of LENSai API

Allay Therapeutics Announces FDA Acceptance Of IND App To Initiate Pivotal Phase 2B Trial Of ATX101

SOLUTIONS

Solid Form Services

Chromatography Method For Purifying Infectious Virus Particles